Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug discovery
Biotech
Enveda envisions clinical wins with $130M series C raise
The Boulder-based biotech sent its lead candidate ENV-294 into a phase 1 trial for atopic dermatitis at the end of October.
Darren Incorvaia
Nov 21, 2024 10:55am
Novartis pays Schrödinger $150M to form drug discovery pact
Nov 12, 2024 8:55am
Evotec attracts private equity buyout interest: report
Nov 11, 2024 9:17am
AbbVie makes Richter richer, paying $25M to form discovery pact
Oct 25, 2024 7:55am
Dotmatics debuts antibody engineering R&D software platform
Oct 22, 2024 2:06pm
Lundbeck taps Charles River for AI-enabled neuro drug discovery
Oct 2, 2024 9:21am
